INAB.NASDAQIn8bio, INC

Form 4: IN8BIO, INC. Executive Acquires Stock Options

Sentiment:

SEC Form 4 Filing

📋All filings for In8bio, INC
🔒Login to Follow

William Tai-Wei Ho, President and CEO of IN8BIO, INC., acquired stock options for 912,450 shares of common stock on February 5, 2025.

Summary

  • On February 5, 2025, William Tai-Wei Ho, the President and CEO of IN8BIO, INC. acquired stock options.
  • The options grant the right to buy 912,450 shares of IN8BIO's common stock at an exercise price of $0.29 per share.
  • The options vest over time, with 25% vesting on February 5, 2026, and the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
  • The options expire on February 5, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard executive compensation disclosure. The grant of options is generally viewed as a positive, aligning management with shareholder interests, but it's not a major event.

Positives

  • The acquisition of stock options by the CEO could align his interests with those of the shareholders, incentivizing him to increase the company's value.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Stakeholder Impact

  • Shareholders may view the option grant as a positive sign, aligning management's interests with the company's long-term success.

Key Dates

DateDescription
02/05/2025Date of the stock option grant.
02/05/2026Date when 25% of the options vest.
02/05/2035Expiration date of the stock options.
02/07/2025Date of signature of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.